サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：医用画像の世界市場-2023年～2030年
市場調査レポート
商品コード
1345423

医用画像の世界市場-2023年～2030年

Global Medical Imaging Market - 2023-2030

出版日
ページ情報
英文 195 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
医用画像の世界市場-2023年～2030年
出版日: 2023年09月06日
発行: DataM Intelligence
ページ情報: 英文 195 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

世界の医用画像市場は、2022年に402億米ドルに達し、2023-2030年の予測期間中にCAGR 5.1%で成長し、2030年には593億米ドルに達すると予測されています。

医用画像には、臨床分析や医療介入のために体内を画像化するプロセスや、臓器や組織の機能を視覚的に表現するプロセスが含まれます。画像処理技術の種類によって、研究対象や治療対象である身体の部位について、考えられる病気や怪我、治療の効果に関連するさまざまな情報が得られます。

医用画像技術は臨床解剖学や法医学病理学に大きな進歩をもたらしました。新しく登場した技術により、医療専門家は人体をさまざまな角度から観察し、理解することができるようになっています。一般的に使用される医用画像機器には、X線、コンピュータ断層撮影（CT）、陽電子放射断層撮影（PET）、超音波、磁気共鳴画像（MRI）などがあります。

さらに、政府や民間組織による投資の増加、製品の上市、研究開発の活発化などの重要な成長促進要因が、将来の市場成長をもたらしています。Koninklijke Philips N.V.、GEヘルスケア、島津製作所、東芝メディカルシステムズなど、その他の主要企業が市場で活発に活動しています。

ダイナミクス

医用画像装置の製品上市が増加し、市場の成長が期待される

医用画像装置は、筋骨格系疾患、心疾患、がん、慢性肺疾患などの慢性疾患の診断に広く使用されています。大手企業による主要な技術的進歩は、市場成長の推進に役立っています。このような効果的な製品の発売は、研究の発見を新しい治療法に変え、慢性疾患を抱える何百万人もの人々のケアを改善するのに役立っています。

例えば、2023年7月、コニカミノルタヘルスケアアメリカズ社は、ポイントオブケアでの一般的な画像診断用の新しいワイヤレスハンドヘルド超音波診断装置であるPocketPro H2を発売しました。ポケットプロH2は、筋骨格系（MSK）、疼痛管理、血管アクセス、針誘導などの用途に最適化されたリニアワイヤレスハンドヘルド超音波システムで、優れた画質を備えています。

さらに、2023年5月、フィリップスはZenition 10と名付けられたPhilips Image Guided Therapy Mobile C-arm System 1000を発売しました。フィリップスのZenition 10は、スピードと効率性を提供することで、高い患者スループットに対応するように設計されています。また、外傷、整形外科、その他の分野の手術に対応できる柔軟性も備えています。このように、上記の要因が市場を後押ししています。

政府と民間組織による投資が世界市場での需要を促進

政府は、世界の医療機器の購入、価格設定、流通において重要な役割を果たしています。政府は、安全で費用対効果の高い医療製品を国民に提供するため、ヘルスケアインフラを整備するさまざまな取り組みを行っています。政府機関による資金援助は、新しい施設の開設にも役立っています。また、輸出入を遵守する規制の実施も、市場の収益創出に貢献すると期待されています。

例えば、英国政府は2023年5月、NHSへの負担を軽減し患者ケアを向上させるため、新たに160の地域診断センターに23億ポンドを出資しました。これにより、年間50万件以上の検診、画像診断、スキャンが追加される見込みです。

さらに2023年3月、カナダの世界的医療技術革新企業であるシナプティブ・メディカル社は、カナダ輸出開発省（EDC）から4,000万米ドルの投資を受け、外科手術、画像診断、データ技術を加速させます。この4,000万米ドルの投資は、カナダ製の外科用ロボット、MRI、医用画像用・手術室用データプラットフォームの開発とアクセス拡大を目的としています。

医用画像機器の製品リコールが世界の医用画像機器市場の成長を妨げる

世界の医用画像機器市場では、過去数年間に大規模な製品リコールが発生しています。製品リコールは、製品の欠陥が消費者に影響を与えたり、危害を加えたり、企業の評判を下げたり、市場の成長を妨げたりする場合に発生します。このような事例が増加した結果、不正確なエラーが発生し、医用画像市場で示された製品リコールのいくつかの主要な事例が発生しています。

例えば、2022年5月26日、アボットメディカルは米国で4,800本のDragonfly OpStarイメージングカテーテルをリコールしました。さらに、2023年2月、GEヘルスケアは重傷または死亡を引き起こす可能性のある核医療画像システムの一部をリコールしました。これはGEの核医学600および800シリーズシステムに関するもので、がんおよび神経疾患の検出と診断に使用されます。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 医用画像装置の上市の増加
      • 政府および民間組織による投資
    • 抑制要因
      • 医用画像装置のリコール
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • アンメットニーズ
  • 規制分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品別

  • X線
  • コンピュータ断層撮影
  • 陽電子放射断層撮影（PET）
  • 超音波診断装置
  • MRI装置
  • 核医学イメージング
  • 触覚イメージング
  • 光音響イメージング
  • サーモグラフィ
  • エラストグラフィー
  • 心エコー検査

第8章 アプリケーション別

  • 心臓病
  • 整形外科
  • 消化器内科
  • 婦人科
  • 腫瘍
  • 神経科
  • その他

第9章 エンドユーザー別

  • 診断センター
  • 病院
  • 専門クリニック
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 製品ベンチマーク
  • 企業シェア分析
  • 主な発展と戦略

第12章 企業プロファイル

  • Koninklijke Philips N.V
    • 企業概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な動向
  • GE Healthcare
  • Shimadzu Corporation
  • Toshiba Medical Systems Inc.
  • Ziehm Imaging Inc.
  • Varian Medical Systems
  • Aribex Corporation
  • Fujifilm Holdings Corporation
  • Siemens Healthcare
  • Hitachi Ltd.

第13章 付録

目次
Product Code: MI213

Overview

Global Medical Imaging Market reached US$ 40.2 billion in 2022 and is expected to reach US$ 59.3 billion by 2030 growing with a CAGR of 5.1% during the forecast period 2023-2030.

Medical imaging involves the process of imaging the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues. Each type of imaging technology gives different information about the area of the body being studied or treated which is related to possible disease, injury, or the effectiveness of medical treatment.

Medical imaging techniques have led to great advances in clinical anatomy and forensic pathology. New and emerging technologies allow healthcare professionals to view and understand the human body from different perspectives. Commonly used medical imaging equipment includes X-rays, computed tomography (CT), positron emission tomography (PET), ultrasound, and magnetic resonance imaging (MRI).

Furthermore, significant growth drivers such as the increasing investments by government and private organizations, product launches, and rising research and developments give rise to future market growth. Significant key players like Koninklijke Philips N.V., GE Healthcare, Shimadzu Corporation, Toshiba Medical Systems Inc., and others are actively operating in the market.

Dynamics

Increasing Product Launches of Medical Imaging Equipment is Expected to Boost Market Growth

Medical imaging devices are widely used in diagnosing chronic conditions like musculoskeletal disorders, cardiac disease, cancers, and chronic lung diseases. The major technological advancements by major companies help to drive market growth. These effective product launches help to transform research discoveries into new treatments and improve care for millions of people with chronic diseases.

For instance, in July 2023, Konica Minolta Healthcare Americas, Inc., launched PocketPro H2, a new wireless handheld ultrasound device for general imaging in point-of-care applications. The PocketPro H2 linear wireless handheld ultrasound system is optimized for musculoskeletal (MSK), pain management, vascular access, and needle guidance applications. with excellent image quality.

Additionally, in May 2023, Philips launched the Philips Image Guided Therapy Mobile C-arm System 1000, named Zenition 10. Philips Zenition 10 is designed to address high patient throughput by providing speed and efficiency. It also provides the flexibility to accommodate the requirements of trauma, orthopedics, and other areas of surgery. Thus, the above factors help to boost the market.

Investments by Government and Private Organizations Fuel its Demand in the Global Market

Government plays an important role in purchasing, pricing, and distributing medical devices globally. Governments undertake various initiatives to develop healthcare infrastructure to provide safe and cost-effective medical products to the public. The funding by government bodies also helps in opening new facilities. Also, implementing regulations that comply with imports and exports is expected to help generate revenue for the market.

For instance, in May 2023, the United Kingdom Government funded £2.3 billion into 160 new community diagnostic centers to reduce pressure on the NHS and improve patient care. It is expected to provide over 500,000 additional checkups, imaging, and scans a year.

Additionally, in March 2023, Synaptive Medical Inc., a global medical technology innovator in Canada, secured a USD $40 million investment from Export Development Canada (EDC) to accelerate surgical, imaging, and data technologies. The $40 million investment is to develop and expand access to Canadian-made surgical robotics, MRI, and data platforms for medical imaging and operating rooms.

Product Recalls Of Medical Imaging Equipment Will Hamper The Global Medical Imaging Equipment Market Growth

The global medical imaging market has witnessed major product recalls in the past few years. Product recalls occur when a product defect could affect or harm the consumer, hampers a company's reputation, and hinders market growth. An increasing number of such instances result in inaccuracy errors and some major instances of product recall witnessed in the medical imaging market.

For instance, on 26 May 2022, Abbott Medical Recalled 4,800 Dragonfly OpStar Imaging Catheters in the U.S. Additionally, in February 2023, GE HealthCare recalled some of its nuclear medicine imaging systems that could cause serious injury or death. It pertains to GE's Nuclear Medicine 600 and 800 Series systems, used for detecting and diagnosing cancer, and neurological disorders.

Segment Analysis

The global medical imaging market is segmented based on product, application, end users, and region.

X-rays from the Product Segment Accounted for Approximately 37.5% of the Global Medical Imaging Market Share

The X-ray segment has the most significant share of the medical imaging equipment market due to the system's versatility and convenience. An X-ray is a noninvasive medical imaging test that helps physicians diagnose and treat medical conditions. X-rays diagnose skeletal systems, oral cavities, lungs, breast, digestive systems, and ingested objects. The growth in the X-ray segment is mainly due to its cost-effectiveness

For instance, in July 2022, Shimadzu Corporation introduced a New Type of Mobile X-ray System Outside of Japan, accommodating a Wide Range of Needs for Mobile X-ray Systems. This system incorporates digital radiography (DR) and this Mobile X-ray system provides diagnostic imaging and can travel to patient rooms, operating rooms, and emergency areas.

For instance, on August 02, 2022, GE Healthcare launched its most advanced fixed X-ray system called the next-generation Definium 656 HD. The Definium 656 HD, featuring the Intelligent Workflow Suite, is a versatile and digital radiographic system powered by GE's FlashPad HD high-resolution detectors and the latest Helix 2.2 advanced image processing software.

Geographical Penetration

North America Accounted for Approximately 38.4% of the Market Share in 2022

North America has maintained a significant proportion of the medical imaging market in recent years, and this trend is anticipated to continue throughout the forecast period due to factors such as rising product launches, healthcare expenditure, and research and developments in medical imaging equipment.

For instance, in August 2023, GE HealthCare launched the handheld ultrasound device Vscan Air SL. The dual-headed probe of Vscan Air SL enables clinicians to access sector and linear arrays on the same device that is capable of facilitating rapid vascular and cardiac assessments of patients.

Competitive Landscape

The major global players in the market include: Koninklijke Philips N.V, GE Healthcare, Shimadzu Corporation, Toshiba Medical Systems Inc., Ziehm Imaging Inc., Varian Medical Sytems, Aribex Corporation, Fujifilm Holdings Corporation, Siemens Healthcare, Hitachi Ltd. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the medical imaging market. During the height of the pandemic, many healthcare systems were overwhelmed, and non-urgent medical procedures and screenings were postponed or canceled. This led to delays in medical imaging device research and product launches. Clinical trials are vital for developing new treatments and improving outcomes in the medical imaging market.

However, the pandemic disrupted the conduct of clinical trials, with many sites temporarily halting enrollment or modifying protocols to prioritize patient safety. This has led to delays in the completion of trials and the availability of new therapies. Moreover, the focus of research and development efforts shifted during the pandemic, with a significant emphasis on developing vaccines and treatments for COVID-19. Therefore, owing to the above factors, the medical imaging market is expected to be moderately affected over the forecast period.

By Product

  • X-Ray
  • Computed Tomography
  • Positron Emission Tomography (PET)
  • Ultrasound System
  • MRI Equipment
  • Nuclear Imaging
  • Tactile Imaging
  • Photoacoustic Imaging
  • Thermography
  • Elastography
  • Echocardiography

By Application

  • Cardiology
  • Orthopedics
  • Gastroenterology
  • Gynecology
  • Oncology
  • Neurology
  • Others

By End Users

  • Diagnostic Centers
  • ASCs
  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In May 2023, Claritas HealthTech entered into a collaboration with PwC for the deployment of its medical imaging platforms. This collaboration helps the companies work together to roll out, install, and support medical image enhancement and artificial intelligence (AI) diagnostic software products suite.
  • In February 2023, Mindray launched the handheld ultrasound system TE Air. TE Air offers crisp, high-quality ultrasound images, and facilitates radiology workflow with seamless integration into hospital information systems and can be connected with other systems.
  • In September 2022, Philips Foundation and RAD-AID International embarked on a multi-year cross-continental partnership to increase access to ultrasound services for 50 million people in low- and middle-income countries.

Why Purchase the Report?

  • To visualize the global medical imaging market segmentation based on product, application, end users, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global medical imaging market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global medical imaging market report would provide approximately 69 tables, 70 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Application
  • 3.3. Snippet by End Users
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing product launches of medical imaging equipment
      • 4.1.1.2. Investments by government and private organizations
    • 4.1.2. Restraints
      • 4.1.2.1. Product recalls of medical imaging equipment
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. X-Ray
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Computed Tomography
  • 7.4. Positron Emission Tomography (PET)
  • 7.5. Ultrasound System
  • 7.6. MRI Equipment
  • 7.7. Nuclear Imaging
  • 7.8. Tactile Imaging
  • 7.9. Photoacoustic Imaging
  • 7.10. Thermography
  • 7.11. Elastography
  • 7.12. Echocardiography

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Cardiology
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Orthopedics
  • 8.4. Gastroenterology
  • 8.5. Gynecology
  • 8.6. Oncology
  • 8.7. Neurology
  • 8.8. Others

9. By End Users

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
    • 9.1.2. Market Attractiveness Index, By End Users
  • 9.2. Diagnostic Centers
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Hospitals
  • 9.4. Specialty Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End Users

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Product Benchmarking
  • 11.3. Company Share Analysis
  • 11.4. Key Developments and Strategies

12. Company Profiles

  • 12.1. Koninklijke Philips N.V*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. GE Healthcare
  • 12.3. Shimadzu Corporation
  • 12.4. Toshiba Medical Systems Inc.
  • 12.5. Ziehm Imaging Inc.
  • 12.6. Varian Medical Systems
  • 12.7. Aribex Corporation
  • 12.8. Fujifilm Holdings Corporation
  • 12.9. Siemens Healthcare
  • 12.10. Hitachi Ltd.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us